2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Keratosis, Actinic
5
Lymphoma, T-Cell, Cutaneous
2
Vascular Malformations
1
Uterine Cervical Dysplasia
1
Surgical Wound Infection
1
Pilonidal Sinus
1
Pancreatic Neoplasms
1
Pain
1
Mycosis Fungoides
1
Keratosis
1
High-grade Anal Intraepithelial Neoplasia
1
Hemangioma, Capillary
1
Hemangioma
1
Head and Neck Neoplasms
1
Dermatitis, Contact
1
Condylomata Acuminata
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Breast Cancer Lymphedema
1
Interventions
Propranolol
9
Timolol
5
Prednisolone
5
Prednisone
3
Adrenergic beta-Antagonists
3
Steroids
2
Solutions
2
Saline Solution
2
Methylprednisolone
2
Adrenal Cortex Hormones
2
prednisolone phosphate
1
Vincristine
1
Urine Specimen Collection
1
Tomography, Optical Coherence
1
Therapeutics
1
Sodium Chloride
1
Sirolimus
1
Population Groups
1
Ointments
1
Observation
1
Nadolol
1
Mupirocin
1
Leuprolide
1
Lasers, Semiconductor
1
Lasers, Dye
1
Imiquimod
1
High-Energy Shock Waves
1
Hepatectomy
1
Gels
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemangioma
×
Ointments
×
Clear all
NCT01408056
2014-01-17
TOUCH
Children's Hospital of Philadelphia
Phase 2
Withdrawn